Aptose Biosciences Inc.
APTOF
$1.71
$0.031.91%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 46.01% | -25.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 51.19% | -29.01% | |||
| Operating Income | -51.19% | 29.01% | |||
| Income Before Tax | -51.45% | 27.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -51.45% | 27.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -51.45% | 27.26% | |||
| EBIT | -51.19% | 29.01% | |||
| EBITDA | -51.45% | 29.13% | |||
| EPS Basic | -51.39% | 27.26% | |||
| Normalized Basic EPS | -51.39% | 27.26% | |||
| EPS Diluted | -51.39% | 27.26% | |||
| Normalized Diluted EPS | -51.39% | 27.26% | |||
| Average Basic Shares Outstanding | 0.05% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||